RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
NewCo’s pipeline includes five investigational medicines
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
Dr. Rao has over 29 years of experience in manufacturing, R&D, business operations, and customer service
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Subscribe To Our Newsletter & Stay Updated